featured
2019 Top Stories in Cardiology: Time for Shortcuts After PCI?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Mehran R, Baber U, Sharma SK, et al. Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. 2019 Sep 26. doi: 10.1056/NEJMoa1908419. [Epub ahead of print.]
- Watanabe H, Domei T, Morimoto T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA. 2019;321(24):2414-2427.
- Hahn JY, Song YB, Oh JH, et al. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial. JAMA. 2019;321(24):2428-2437.
Disclosure statements are available on the authors' profiles: